0 Commentarii
0 Distribuiri
1K Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGRAccording to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGRAccording to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGRAccording to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Unfractionated Heparin Market Segmentation Analysis by Dosage Form and End UserThe global unfractionated heparin market continues to play a vital role in the healthcare industry due to the widespread use of anticoagulants in preventing and treating thromboembolic disorders. Unfractionated heparin (UFH) remains one of the most commonly used anticoagulant therapies in hospitals and clinical settings because of its rapid onset of action, established safety profile, and...0 Commentarii 0 Distribuiri 649 Views 0 previzualizare